BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24373835)

  • 1. Polymeric delivery systems for dexamethasone.
    Urbańska J; Karewicz A; Nowakowska M
    Life Sci; 2014 Feb; 96(1-2):1-6. PubMed ID: 24373835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor efficacy of dexamethasone-loaded core-crosslinked polymeric micelles.
    Coimbra M; Rijcken CJ; Stigter M; Hennink WE; Storm G; Schiffelers RM
    J Control Release; 2012 Nov; 163(3):361-7. PubMed ID: 23041274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel controlled local drug delivery system for inner ear disease.
    Paulson DP; Abuzeid W; Jiang H; Oe T; O'Malley BW; Li D
    Laryngoscope; 2008 Apr; 118(4):706-11. PubMed ID: 18182968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copolymeric nanofilm platform for controlled and localized therapeutic delivery.
    Chow EK; Pierstorff E; Cheng G; Ho D
    ACS Nano; 2008 Jan; 2(1):33-40. PubMed ID: 19206545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation of dexamethasone to C60 for the design of an anti-inflammatory nanomedicine with reduced cellular apoptosis.
    Zhang Y; Wang L; Sun Y; Zhu Y; Zhong Z; Shi J; Fan C; Huang Q
    ACS Appl Mater Interfaces; 2013 Jun; 5(11):5291-7. PubMed ID: 23669026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLGA-PEG-PLGA hydrogel for ocular drug delivery of dexamethasone acetate.
    Gao Y; Sun Y; Ren F; Gao S
    Drug Dev Ind Pharm; 2010 Oct; 36(10):1131-8. PubMed ID: 20334543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local drug delivery system: inhibition of inflammatory angiogenesis in a murine sponge model by dexamethasone-loaded polyurethane implants.
    Moura SA; Lima LD; Andrade SP; Da Silva-Cunha A; Órefice RL; Ayres E; Da Silva GR
    J Pharm Sci; 2011 Jul; 100(7):2886-95. PubMed ID: 21283986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting.
    Seki J; Sonoke S; Saheki A; Fukui H; Sasaki H; Mayumi T
    Int J Pharm; 2004 Apr; 273(1-2):75-83. PubMed ID: 15010132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porous antioxidant polymer microparticles as therapeutic systems for the airway inflammatory diseases.
    Jeong D; Kang C; Jung E; Yoo D; Wu D; Lee D
    J Control Release; 2016 Jul; 233():72-80. PubMed ID: 27151077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative anti-inflammatory activity of poly(amidoamine) (PAMAM) dendrimer-dexamethasone conjugates with dexamethasone-liposomes.
    Choksi A; Sarojini KV; Vadnal P; Dias C; Suresh PK; Khandare J
    Int J Pharm; 2013 Jun; 449(1-2):28-36. PubMed ID: 23583708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-efficacy site-directed drug delivery system using sialyl-Lewis X conjugated liposome.
    Hashida N; Ohguro N; Yamazaki N; Arakawa Y; Oiki E; Mashimo H; Kurokawa N; Tano Y
    Exp Eye Res; 2008 Jan; 86(1):138-49. PubMed ID: 18036523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window].
    Chen G; Hou SX; Hu P; Hu QH; Guo DD; Xiao Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1022-4. PubMed ID: 18583254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery.
    Kim DH; Martin DC
    Biomaterials; 2006 May; 27(15):3031-7. PubMed ID: 16443270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release pattern of dexamethasone after administration through an implant-mediated drug delivery device with an active plunger of super absorbent polymer.
    Yang ST; Park YS
    Drug Deliv Transl Res; 2018 Jun; 8(3):702-707. PubMed ID: 29626335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local release of dexamethasone from polymer millirods effectively prevents fibrosis after radiofrequency ablation.
    Blanco E; Weinberg BD; Stowe NT; Anderson JM; Gao J
    J Biomed Mater Res A; 2006 Jan; 76(1):174-82. PubMed ID: 16265662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices.
    Hickey T; Kreutzer D; Burgess DJ; Moussy F
    J Biomed Mater Res; 2002 Aug; 61(2):180-7. PubMed ID: 12007197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cation instructed steroidal prodrug supramolecular hydrogel.
    Zhou Y; Lei L; Zhang Z; Zhang R; Song Q; Li X
    J Colloid Interface Sci; 2018 Oct; 528():10-17. PubMed ID: 29803956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis.
    Wang D; Miller SC; Liu XM; Anderson B; Wang XS; Goldring SR
    Arthritis Res Ther; 2007; 9(1):R2. PubMed ID: 17233911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser-induced intrachoroidal dexamethasone drug delivery system to posterior eye segment.
    Murata M; Sanbe A; Lee JW; Nishigori H
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8317-24. PubMed ID: 24265021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II results of an intraocular steroid delivery system for cataract surgery.
    Chang DF; Garcia IH; Hunkeler JD; Minas T
    Ophthalmology; 1999 Jun; 106(6):1172-7. PubMed ID: 10366088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.